Research Papers:
Krüppel-like factor 2 suppresses human gastric tumorigenesis through inhibiting PTEN/AKT signaling
PDF | HTML | Supplementary Files | How to cite
Metrics: PDF 3348 views | HTML 2440 views | ?
Abstract
Chunmei Wang1,2,3,*, Liang Li1,*, Qiuhui Duan1, Qingqing Wang4 and Jinlian Chen1,2
1Joint Research Center for Translational Medicine, East China Normal University and Shanghai Fengxian District Central Hospital, Shanghai 201499, China
2Department of Gastroenterology, Affiliated Fengxian Hospital of Southern Medical University, Shanghai 201499, China
3Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China
4Department of Gastroenterology, Affiliated Fengxian Hospital of Anhui University of Science and Technology, Shanghai 201499, China
*These authors have contributed equally to this work
Correspondence to:
Jinlian Chen, email: [email protected]
Keywords: KLF2; gastric cancer; prognosis; tumor suppressor; PTEN-AKT-mTOR signaling
Received: April 25, 2017 Accepted: October 05, 2017 Published: November 01, 2017
ABSTRACT
Krüppel-like factors (KLFs) are a large family of DNA-binding transcriptional regulators that affect basic cellular processes such as growth, survival, migration and differentiation and serve a complicated function in cancers. KLF2, one member of the KLF family, is dysregulated in many tumors. However, the specific role of KLF2 in human gastric tumorigenesis is unknown. Here we show that the expression of KLF2 protein was lower in gastric tumors when compared with adjacent normal tissue. Moreover, downregulated KLF2 expression in primary gastric tumor was closely correlated with patients’ survival. Various cell experiments showed that ectopic KLF2 expression suppressed the proliferation, migration and invasion of gastric cancer cells. Moreover, KLF2 overexpression remarkably enhanced cell apoptosis and induced cell cycle arrest. Impaired expression of KLF2 markedly promoted cell growth in vitro and significantly expanded tumor size in vivo. Mechanically, the mRNA and protein level of PTEN was reduced in KLF2 deficient cells and xenograft tumors, suggesting that PTEN/AKT signaling was involved in the gastric tumor inhibitory effect of KLF2. Administration of AKT inhibitor AZD5363 or Insulin-like growth factor-1 (IGF-1) in KLF2 knockdown or ectopic expression cell lines, respectively, substantially reversed the proliferation phenotype. Collectively, our findings provide clinical evidence and a potential mechanism supporting that KLF2 suppresses human gastric tumorigenesis through inhibiting the PTEN/AKT axis.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 22229